An extreme example of the potential success of BRAF ± MEK inhibition in papillary craniopharyngioma is demonstrated in a case report of a patient with radiographic evidence of craniopharyngioma, but refusal of surgical resection or biopsy for tissue diagnosis [17]. The gene discussed is BRAF; the disease is Papillary Craniopharyngioma.